Malignant Solid Tumor
Conditions
Interventions
Gold Standard:Pathological Diagnosis
Index test:Histone Succinylation Modification in Serum
Sponsors
The First Affiliated Hospital of Xinxiang Medical University
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Case group 1. >= 18 years old, regardless of gender; 2. Malignant solid tumors confirmed by cytology or histology, which require subsequent anti-tumor therapy (systemic therapy, or radical simultaneous radiotherapy/radiotherapy, or surgical treatment); Control group 1. >= 18 years old, regardless of gender; 2. Non-oncology patients with health check-ups.
Exclusion criteria
Exclusion criteria: 1.Pregnant individuals; 2.Individuals with severe psychiatric disorders or language/communication disorders; 3.Other conditions that, in the investigator's judgment, may compromise patient safety or data validity;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Measurement of histone succinylation in human serum samples; | — |
Countries
China
Contacts
Public ContactPing Lu
The First Affiliated Hospital of Xinxiang Medical University
Outcome results
None listed